Virbac SA
PAR:VIRP

Watchlist Manager
Virbac SA Logo
Virbac SA
PAR:VIRP
Watchlist
Price: 323.5 EUR 0.15% Market Closed
Market Cap: 2.7B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+128%
Revenue
Forecast
+24%
Operating Income
Forecast
+2%
Net Income
Forecast
+5%

Wall Street
Price Targets

VIRP Price Targets Summary
Virbac SA

Wall Street analysts forecast VIRP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VIRP is 387.92 EUR with a low forecast of 323.2 EUR and a high forecast of 449.93 EUR.

VIRP Lowest Forecast
Wall Street Target
323.2 EUR
0% Downside
VIRP Average Forecast
Wall Street Target
387.92 EUR
20% Upside
VIRP Highest Forecast
Wall Street Target
449.93 EUR
39% Upside
Lowest
Price Target
323.2 EUR
0% Downside
Average
Price Target
387.92 EUR
20% Upside
Highest
Price Target
449.93 EUR
39% Upside
Virbac SA Competitors:
Price Targets
U
3933
United Laboratories International Holdings Ltd
1% Upside
1477
Ocumension Therapeutics
33% Downside
4554
Fuji Pharma Co Ltd
66% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
91% Upside
U
3933
United Laboratories International Holdings Ltd
1% Upside
1477
Ocumension Therapeutics
33% Downside
4554
Fuji Pharma Co Ltd
66% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
91% Upside
000100
Yuhan Corp
44% Upside
2161
Jbm (Healthcare) Ltd
9% Upside

Revenue
Forecast

Revenue Estimate
Virbac SA

For the last 13 years the compound annual growth rate for Virbac SA's revenue is 6%. The projected CAGR for the next 3 years is 5%.

6%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Virbac SA

For the last 13 years the compound annual growth rate for Virbac SA's operating income is 8%. The projected CAGR for the next 3 years is 6%.

8%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Virbac SA

For the last 13 years the compound annual growth rate for Virbac SA's net income is 7%. The projected CAGR for the next 3 years is 12%.

7%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
VIRP intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIRP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIRP stock valuation using valuation multiples.
Wall Street Estimates
VIRP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIRP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VIRP's stock price target?
Price Target
387.92 EUR

According to Wall Street analysts, the average 1-year price target for VIRP is 387.92 EUR with a low forecast of 323.2 EUR and a high forecast of 449.93 EUR.

What is Virbac SA's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Virbac SA's revenue is 6%. The projected CAGR for the next 3 years is 5%.

What is Virbac SA's Operating Income forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Virbac SA's operating income is 8%. The projected CAGR for the next 3 years is 6%.

What is Virbac SA's Net Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Virbac SA's net income is 7%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.